BMO Capital Markets Cuts UiPath (NYSE:PATH) Price Target to $11.50
UiPath (NYSE:PATH – Free Report) had its price target reduced by BMO Capital Markets from $16.00 to $11.50 in a report ...
goeasy (TSE:GSY) Upgraded at BMO Capital Markets
BMO Capital Markets upgraded shares of goeasy (TSE:GSY – Free Report) from a market perform rating to an outperform rating in ...
BMO's top oil & gas analyst eyes four-way 'Montney Mash' mega merger
Bank of Montreal’s veteran oil and gas analyst is making the case for a four-way mega merger in Western Canada’s Montney Formation, arguing such a deal would boost scale and broaden investor appeal.
Business Wire6d
Nutrien Prices Offering of an Aggregate of US$1.0 Billion of 2-Year and 7-Year Senior Notes
Nutrien Ltd. (TSX and NYSE: NTR) today announced the pricing of US$400 million aggregate principal amount of 4.500 percent ...
Yahoo Finance6d
BMO Capital Initiates Coverage on Dyne Therapeutics With Outperform Rating
BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of ...
Lack of follow-through in post-CPI Treasury rally shows traders focused on tariff fears: strategist
A cooler-than-expected February consumer-price index is stoking a relief bounce in stock-index futures and triggered an initial surge higher in Treasurys, which pulled down yields, which move opposite ...
Okta price target raised to $130 from $105 at BMO Capital
BMO Capital raised the firm’s price target on Okta (OKTA) to $130 from $105 and keeps a Market Perform rating on the shares. The firm had been ...
SailPoint initiated with an Outperform at BMO Capital
BMO Capital analyst Keith Bachman initiated coverage of SailPoint (SAIL) with an Outperform rating and $26 price target The firm believes ...